{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:29:36Z","timestamp":1785713376007,"version":"3.56.0"},"reference-count":11,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2008,8,20]]},"DOI":"10.1200\/jco.2007.15.5424","type":"journal-article","created":{"date-parts":[[2008,8,18]],"date-time":"2008-08-18T22:23:22Z","timestamp":1219098202000},"page":"4037-4038","source":"Crossref","is-referenced-by-count":197,"title":["Osteonecrosis of the Jaw Related to Bevacizumab"],"prefix":"10.1200","volume":"26","author":[{"given":"Cherry L.","family":"Estilo","sequence":"first","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Fornier","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeez","family":"Farooki","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Carlson","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George","family":"Bohle","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Huryn","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","unstructured":"Van Poznak C, Estilo C: Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. Oncology (Williston Park) 20:1053,2006-1062,"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00009"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc905"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.10.088"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050874"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.098"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.3026"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9337-9"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.11.015"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-1-85"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-10-1070"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2007.15.5424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:18:18Z","timestamp":1653509898000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.15.5424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,20]]},"references-count":11,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2008,8,20]]}},"alternative-id":["10.1200\/JCO.2007.15.5424"],"URL":"https:\/\/doi.org\/10.1200\/jco.2007.15.5424","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,20]]}}}